Dupont Capital Management Corp Kodiak Sciences Inc. Transaction History

Dupont Capital Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$77.2 - $126.54 $128,306 - $210,309	-1,662 Closed	0 $0
Q1 2021 Apr 29, 2021	SELL	$110.45 - $164.47 $37,773 - $56,248	-342 Reduced 17.07%	1,662 $188,000
Q4 2020 Jan 28, 2021	SELL	$60.78 - $154.03 $76,825 - $194,693	-1,264 Reduced 38.68%	2,004 $294,000
Q3 2020 Oct 29, 2020	SELL	$45.05 - $59.27 $9,865 - $12,980	-219 Reduced 6.28%	3,268 $193,000
Q2 2020 Jul 24, 2020	BUY	$42.74 - $66.25 $149,034 - $231,013	3,487 New	3,487 $189,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $498M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.